Cargando…

Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum

Antiviral culinary plants are potential bioresources for preventive nutraceuticals and/or antiviral drugs in COVID-19. Structure-based virtual screening was undertaken to screen 173 compounds previously reported from Vernonia amygdalina and Occinum gratissimum for direct interaction with the active...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyebi, Gideon A., Elfiky, Abdo A., Ogunyemi, Oludare M., Ibrahim, Ibrahim M., Adegunloye, Adegbenro P., Adebayo, Joseph O., Olaiya, Charles O., Ocheje, Joshua O., Fabusiwa, Modupe M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294106/
https://www.ncbi.nlm.nih.gov/pubmed/34332348
http://dx.doi.org/10.1016/j.compbiomed.2021.104671
_version_ 1783725174043967488
author Gyebi, Gideon A.
Elfiky, Abdo A.
Ogunyemi, Oludare M.
Ibrahim, Ibrahim M.
Adegunloye, Adegbenro P.
Adebayo, Joseph O.
Olaiya, Charles O.
Ocheje, Joshua O.
Fabusiwa, Modupe M.
author_facet Gyebi, Gideon A.
Elfiky, Abdo A.
Ogunyemi, Oludare M.
Ibrahim, Ibrahim M.
Adegunloye, Adegbenro P.
Adebayo, Joseph O.
Olaiya, Charles O.
Ocheje, Joshua O.
Fabusiwa, Modupe M.
author_sort Gyebi, Gideon A.
collection PubMed
description Antiviral culinary plants are potential bioresources for preventive nutraceuticals and/or antiviral drugs in COVID-19. Structure-based virtual screening was undertaken to screen 173 compounds previously reported from Vernonia amygdalina and Occinum gratissimum for direct interaction with the active site of the 3-Chymotrypsin-Like Protease (3CL(pro)) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on docking scores and comparison with reference inhibitors, a hit-list of 10 top phytocompounds was defined, which also had strong interactions with the catalytic centre of 3CL(pro) from three related strains of coronavirus (SARS-CoV, MERS-CoV, HKU4). Among these, six compounds (neoandrographolide, vernolide, isorhamnetin, chicoric acid, luteolin, and myricetin) exhibited the highest binding tendencies to the equilibrated conformers of SARS-CoV-2 3CL(pro) in an in-depth docking analysis to 5 different representative conformations from the cluster analysis of the molecular dynamics simulation (MDS) trajectories of the protein. In silico drug-likeness analyses revealed two drug-like terpenoids viz: neoandrographolide and vernolide as promising inhibitors of SARS-CoV-2 3CL(pro). These structures were accommodated within the substrate-binding pocket; and interacted with the catalytic dyad (Cys(145) and His(41)), the oxyanion loop (residues 138–145), and the S1/S2 sub-sites of the enzyme active site through the formation of an array of hydrogen bonds and hydrophobic interactions. Molecular dynamics simulation and binding free energy calculation revealed that the terpenoid-enzyme complexes exhibit strong interactions and structural stability. Therefore, these compounds may stabilize the conformation of the flexible oxyanion loop; and thereby interfere with the tetrahedral oxyanion intermediate formation during the proteolytic activity of the enzyme.
format Online
Article
Text
id pubmed-8294106
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82941062021-07-21 Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum Gyebi, Gideon A. Elfiky, Abdo A. Ogunyemi, Oludare M. Ibrahim, Ibrahim M. Adegunloye, Adegbenro P. Adebayo, Joseph O. Olaiya, Charles O. Ocheje, Joshua O. Fabusiwa, Modupe M. Comput Biol Med Article Antiviral culinary plants are potential bioresources for preventive nutraceuticals and/or antiviral drugs in COVID-19. Structure-based virtual screening was undertaken to screen 173 compounds previously reported from Vernonia amygdalina and Occinum gratissimum for direct interaction with the active site of the 3-Chymotrypsin-Like Protease (3CL(pro)) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on docking scores and comparison with reference inhibitors, a hit-list of 10 top phytocompounds was defined, which also had strong interactions with the catalytic centre of 3CL(pro) from three related strains of coronavirus (SARS-CoV, MERS-CoV, HKU4). Among these, six compounds (neoandrographolide, vernolide, isorhamnetin, chicoric acid, luteolin, and myricetin) exhibited the highest binding tendencies to the equilibrated conformers of SARS-CoV-2 3CL(pro) in an in-depth docking analysis to 5 different representative conformations from the cluster analysis of the molecular dynamics simulation (MDS) trajectories of the protein. In silico drug-likeness analyses revealed two drug-like terpenoids viz: neoandrographolide and vernolide as promising inhibitors of SARS-CoV-2 3CL(pro). These structures were accommodated within the substrate-binding pocket; and interacted with the catalytic dyad (Cys(145) and His(41)), the oxyanion loop (residues 138–145), and the S1/S2 sub-sites of the enzyme active site through the formation of an array of hydrogen bonds and hydrophobic interactions. Molecular dynamics simulation and binding free energy calculation revealed that the terpenoid-enzyme complexes exhibit strong interactions and structural stability. Therefore, these compounds may stabilize the conformation of the flexible oxyanion loop; and thereby interfere with the tetrahedral oxyanion intermediate formation during the proteolytic activity of the enzyme. Elsevier Ltd. 2021-09 2021-07-21 /pmc/articles/PMC8294106/ /pubmed/34332348 http://dx.doi.org/10.1016/j.compbiomed.2021.104671 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gyebi, Gideon A.
Elfiky, Abdo A.
Ogunyemi, Oludare M.
Ibrahim, Ibrahim M.
Adegunloye, Adegbenro P.
Adebayo, Joseph O.
Olaiya, Charles O.
Ocheje, Joshua O.
Fabusiwa, Modupe M.
Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
title Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
title_full Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
title_fullStr Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
title_full_unstemmed Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
title_short Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
title_sort structure-based virtual screening suggests inhibitors of 3-chymotrypsin-like protease of sars-cov-2 from vernonia amygdalina and occinum gratissimum
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294106/
https://www.ncbi.nlm.nih.gov/pubmed/34332348
http://dx.doi.org/10.1016/j.compbiomed.2021.104671
work_keys_str_mv AT gyebigideona structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT elfikyabdoa structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT ogunyemioludarem structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT ibrahimibrahimm structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT adegunloyeadegbenrop structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT adebayojosepho structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT olaiyacharleso structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT ochejejoshuao structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum
AT fabusiwamodupem structurebasedvirtualscreeningsuggestsinhibitorsof3chymotrypsinlikeproteaseofsarscov2fromvernoniaamygdalinaandoccinumgratissimum